Blood Cancers | Tumor

How Bispecific Antibodies Work and What Patients Can Expect

August 26th 2024, 9:00pm

Article

Bispecific antibodies connect the immune system with cancer cells. They offer an efficacious treatment option, but there are side effects.

6 FDA Cancer Approvals from August 2024

August 21st 2024, 7:00pm

Article

In August 2024, the FDA approved six new cancer treatments, including some that haven’t previously been approved.

Cancer Survivors and Olympians Need to Be in Tune With Their Bodies

August 9th 2024, 5:00pm

Article

Just like athletes in the Olympics, it's important for cancer survivors to keep track of everything they feel and to know their bodies well.

NCCN Recommends Rytelo for Anemia in Patients With MDS

August 7th 2024, 9:00pm

Article

The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions.

After CAR-T Cell Therapy, Monitor for These Symptoms at Home

August 6th 2024, 7:00pm

Video

Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.

Navigating CML: Tools to Empower Patients and Caregivers

July 31st 2024, 3:22pm

Video

Joannie Clements, a patient advocate, provides insights on helping newly diagnosed patients with CML and their caregivers navigate the complexities of diagnosis, and Claire Saxton outlines resources available for them.

Understanding CML: Your Journey from Diagnosis to Treatment

July 31st 2024, 3:14pm

Video

A panel of experts on introduce a discussion on chronic myeloid leukemia (CML) with an overview of the disease, focusing on its subtypes and characteristics.

Iopofosine I 131 Is Promising Across Waldenstrom’s Macroglobulinemia Types

July 24th 2024, 3:00pm

Article

Eighty percent of patients with relapsed or refractory Waldenstrom’s macroglobulinemia responded to treatment with iopofosine I 131, researchers found.

5 Factors Linked to Greater Chance of Polycythemia Vera Progression

July 23rd 2024, 3:00pm

Article

Researchers identified five traits that may increase a person’s chance of experiencing polycythemia vera progression.

Iclusig Leads to Better Responses Than Gleevec in Leukemia Subset

July 17th 2024, 3:00pm

Article

Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia had better MRD statuses after receiving Iclusig, compared with Gleevec.